Pfizer considers purchase of India's Agila Specialties - report
REUTERS - Pfizer Inc is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd (STAR.NS), for a possible price of $2 billion, Bloomberg reported on Monday.
Pfizer is doing due diligence and a deal could be reached this quarter, Bloomberg reported, citing unnamed sources.
A Pfizer spokeswoman said the company does not comment on market rumours or speculation.
Agila makes cancer treatments and antibiotics, Bloomberg said.
Pfizer shares were up 23 cents at $26.75 on the New York Stock Exchange. (Reporting By Caroline Humer; editing by John Wallace)
- Tweet this
- Share this
- Digg this
- Quietly, Brad Pitt and Angelina Jolie say, 'I do'
- UPDATE 2-Abercrombie to shed logo-centric clothes in N. America
- Comedian Joan Rivers, 81, rushed to New York hospital
- UPDATE 3-Comedian Joan Rivers, 81, rushed to New York hospital
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
Prime Minister Narendra Modi promised on Thursday to end "financial untouchability" with a scheme to ensure the majority of households in his country of nearly 1.3 billion people has a bank account within months. Full Article
Adani buys Australia coal mine royalty rights from Linc for $145 million Full Article